Steven J. Mento
Overview
Steven J. Mento received an average of $1M in total compensation, including $432K in salary, at Conatus Pharmaceuticals from 2012 to 2022.
2022Conatus PharmaceuticalsPresident & Chief Executive Officer
2021Conatus PharmaceuticalsPresident & Chief Executive Officer
2020Conatus PharmaceuticalsFormer President, Chief Executive Officer Director
2019Conatus PharmaceuticalsFormer President, Chief Executive Officer Director
2018Conatus PharmaceuticalsPresident and Chief Executive Officer
2017Conatus PharmaceuticalsPresident and Chief Executive Officer
2016Conatus PharmaceuticalsPresident and Chief Executive Officer
2015Conatus PharmaceuticalsPresident and Chief Executive Officer
2014Conatus PharmaceuticalsPresident and Chief Executive Officer
2013Conatus PharmaceuticalsPresident and Chief Executive Officer
Source: SEC filings on May 1, 2023, April 15, 2021, April 30, 2019, April 27, 2018, April 28, 2016, April 28, 2015, and April 28, 2014.
Related executives
We found nine more executives who work or worked at Conatus Pharmaceuticals.
Susan Knudson
Conatus Pharmaceuticals
Chief Financial Officer
Joyce Reyes
Conatus Pharmaceuticals
Senior Vice President of Regulatory, Quality, Clinical Operations & Technical Operations
Richard Pascoe
Conatus Pharmaceuticals
Chief Executive Officer
Gail Naughton
Conatus Pharmaceuticals
Chief Scientific Officer
Keith Marshall
Conatus Pharmaceuticals
Chief Financial Officer
David Hagerty
Conatus Pharmaceuticals
Executive Vice President, Clinical Development
Alfred Spada
Conatus Pharmaceuticals
Chief Scientific Officer
Charles Cashion
Conatus Pharmaceuticals